| 영문 | erythema | 한글 | 홍반 |
|---|---|---|---|
| 설명 | 울혈-염증-상피박리 등의 원인으로 피부나 점막에 오는 여러 자기 모양의 적색 반점. 피부가 국한성으로 홍색을 띠는 일. 유리판으로 압박하면 퇴색하여 보이고, 유리를 떼면 색이 다시 살아난다. 대부분 염증성으로 홍역이나 성홍열에서 볼 수 있는 진피 상층의 모세혈관의 확장-충혈에 의한 것과, 단순성 혈관종에서 볼 수 있는 혈관의 신생에 의한 것이 있다. |
||
| 영문 | radiation dose | 한글 | 방사선량 |
|---|---|---|---|
| 설명 | 방사선조사의 정도. 방사선생물학이나 인체의 방사선방호에서는 전리방사선의 양, 즉 선량이 문제가 된다. 방사선량에서도 국제단위계(SI)가 채용되어 국제방사선방호위원회(ICRP)의 권고에 따라서 다음의 여러 단위가 널리 사용된다. ① 흡수선량(absorbed dose). 물질의 단위질량이 방사선에 의해 받아들이는 에너지. 이 단위는 방사선 및 물질의 종류가 어떠한 것이더라도 사용할 수 있다. 국제단위는 J/kg이며 이것에 고유한 명칭으로 그레이(gray, 기호 Gy)가 부여된다. 1Gy=100라드(rad). ② 조사선량(exposure) 또는 공중선량. X선 또는 γ선에 한해서 사용된다. 국제단위는 C/kg. ③ 선량당량(dose equivalent). 방사선방호를 위해 사용되는 양. 기호는 H. H는 방사선의 종류와 에너지에 의해 생체에 주는 효과를 보정하는 선질계수(Q)와 그 밖의 인자(예를 들면 선량률, 방사성동위원소에 의한 내부피폭시에는 그 핵종의 체내분포 등)에 근거한 보정계수(N)를 흡수선량(D)에 곱한 것, 즉 H=D-Q-N. 또한 D의 단위를 Gy 또는 rad로 표시하였을 때 H의 단위를 각각 시베르트(sievert, 기호 Sv) 및 렘(rem)이라고 한다. 따라서 1 Sv=102rem. 일반적으로 단위시간당의 선량을 선량률(dose rate)이라고 한다. |
||
| 영문 | dose | 한글 | 용량, 투여량, 방사선량 |
|---|---|---|---|
| 설명 | 1. 약제를 한 번 또는 하루에 사용하거나 복용하는 분량. 2. 물질이나 조직에 대한 방사선의 작용 정도를 나타내는 양. 즉, 방사선량이라는 개념은 어떤 한 점에 입사하는 방사선과 그 점 근처에 있는 물질에 대한 방사선의 물리적-화학적-생물학적 효과와의 관게를 정량적으로 나타내는 공통인 척도로서 생각된 것이다. 라드(rad)로 나타내는 흡수량, 렌트겐(R)으로 나타내는 조사 선량, 렘(rem)으로 나타내는 선량 당량으로 구분하여 쓴다. |
||
| 영문 | skin dose | 한글 | 피부선량 |
|---|---|---|---|
| 설명 | 1. 피부표면에서의 방사선의 공중선량으로 여기에는 1차방사선과 후방산란이 포함된다. 2. 피부에 흡수되는 선량. |
||
| MRD | maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme... |
|---|---|
| ID | identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ... |
| MPD | main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe... |
| TD | tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus... |
| DED | date of expected delivery; defined exposure dose; delayed erythema dose |
| MED | Minimal Erythema Dose |
|---|---|
| MED | minimum erythema dose |
| MED | Minimal effective dose |
| MPD | Minimal phototoxic dose |
| E.M. | Erythema Multiforme |
| minimal dose | <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult. (05 Mar 2000) |
|---|---|
| minimal infecting dose | <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures). (05 Mar 2000) |
| minimal lethal dose | <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation). When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05. See: lethal dose. (05 Mar 2000) |
| minimal reacting dose | The minimal dose of a toxic substance causing a reaction, as manifested in the skin of a series of susceptible test animals; the assay is based on the development of a characteristic, minimal but definite, "standard," focal inflammation (congestion and oedema, induration, degenerative changes, and desquamation of epidermal cells). (05 Mar 2000) |
| erythema dose | The minimum amount of X-rays or other form of radiation sufficient to produce erythema; historically, this dose was indicated by the Sabouraud meter as the B tint, the Holzknecht as 5(5H), the Hampson as 4, and the Kienbock as 10. (05 Mar 2000) |
| minimal | Smallest or least, the smallest possible. Origin: L. Minimus = least (18 Nov 1997) |
| minimal air | The volume of gas that remains in the lungs and cannot be expelled after they have been removed from the body, or after the chest has been opened. (05 Mar 2000) |
| minimal alveolar concentration | The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics. Synonym: minimal anaesthetic concentration. (05 Mar 2000) |
| minimal amplitude nystagmus | Nystagmus of so small an amplitude that it is not detected by the usual clinical tests. Synonym: minimal amplitude nystagmus. Origin: micro-+ G. Nystagmos, a nodding (05 Mar 2000) |
| minimal anaesthetic concentration | The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics. Synonym: minimal anaesthetic concentration. (05 Mar 2000) |
| minimal brain dysfunction | An inability to control behaviour due to difficulty in processing neural stimuli. (12 Dec 1998) |
| minimal-change disease | <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure. This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness. It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown. Risk factors include a history for a immune disorder, recent immunisation or a bee sting. Diagnosis is made by renal biopsy. Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented. Synonym: lipoid nephrosis (27 Sep 1997) |
| minimal-change nephrotic syndrome | <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure. This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness. It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown. Risk factors include a history for a immune disorder, recent immunisation or a bee sting. Diagnosis is made by renal biopsy. Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented. Synonym: lipoid nephrosis (27 Sep 1997) |
| minimal deviation melanoma | <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis. (05 Mar 2000) |
| minimal inhibitory concentration | <microbiology, pharmacology> The lowest concentration of antibiotic sufficient to inhibit bacterial growth when tested in vitro. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|